Back to ACL Stock Lookup

Alcon, Inc. (ACL) – Press Releases

Jun 20, 2014 05:30 AM Alchemia Announces First Patient Enrolled in Investigator-Led Phase II Trial of HA-Irinotecan and Erbitux ("CHIME" Trial)
Jun 5, 2014 07:51 PM Alchemia Updates Timeline for Completion of Pivotal Phase III Trial of HA-Irinotecan in Metastatic Colorectal Cancer

Back to ACL Stock Lookup